Home digital prescription of physical activity for people with cancer
The ICT Based Prescription of Physical Activity for Oncology Patients at Their Home: the EASYDOM Trial
Federico II University · NCT07021196
This project will test whether a digital program that prescribes at-home exercise helps breast and prostate cancer patients who are about to start adjuvant treatment.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Federico II University (other) |
| Locations | 1 site (Naples) |
| Trial ID | NCT07021196 on ClinicalTrials.gov |
What this trial studies
This observational study uses information and communication technology (ICT) to deliver and monitor personalized at-home physical activity prescriptions for oncology patients. It enrolls women with breast cancer and men with prostate cancer who are eligible for adjuvant treatment and excludes those who are already actively exercising. Participants will receive digitally guided exercise plans and their adherence, physical function, and patient-reported outcomes will be tracked remotely. The study is led by the University of Naples Federico II and conducted at its Naples site.
Who should consider this trial
Good fit: Ideal candidates are women with breast cancer or men with prostate cancer who are about to begin adjuvant treatment and are not already regularly physically active.
Not a fit: Patients who are already highly active before enrollment or who have medical reasons preventing exercise are unlikely to benefit from this intervention.
Why it matters
Potential benefit: If successful, this approach could make it easier for patients to follow tailored home exercise plans that improve fitness, reduce treatment-related side effects, and enhance quality of life.
How similar studies have performed: Previous randomized and observational studies have shown that structured exercise benefits cancer patients, and early evidence suggests digitally delivered home programs can improve access and adherence though results vary.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Female patients affected by breast cancer eligible for adiuvant treatment * Male patients affected by prostatic cancer eligible for adiuvant treatment Exclusion Criteria: * Active life stily before enrollment
Where this trial is running
Naples
- Federico II University — Naples, Italy (RECRUITING)
Study contacts
- Study coordinator: Guido Iaccarino, Full Professor
- Email: afa.federico2@gmail.com
- Phone: +390817463697
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Cancer